Cargando…

Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort

Introduction: Nowadays, two strategies are available for the management of the clinically negative neck in early-stage (cT1-2N0) oral squamous cell carcinoma (OSCC): elective neck dissection (END) and sentinel lymph node biopsy (SLNB). SLNB stages both the ipsilateral and the contralateral neck in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahieu, Rutger, den Toom, Inne J., Boeve, Koos, Lobeek, Daphne, Bloemena, Elisabeth, Donswijk, Maarten L., de Keizer, Bart, Klop, W. Martin C., Leemans, C. René, Willems, Stefan M., Takes, Robert P., Witjes, Max J. H., de Bree, Remco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103896/
https://www.ncbi.nlm.nih.gov/pubmed/33968742
http://dx.doi.org/10.3389/fonc.2021.644306
_version_ 1783689382374408192
author Mahieu, Rutger
den Toom, Inne J.
Boeve, Koos
Lobeek, Daphne
Bloemena, Elisabeth
Donswijk, Maarten L.
de Keizer, Bart
Klop, W. Martin C.
Leemans, C. René
Willems, Stefan M.
Takes, Robert P.
Witjes, Max J. H.
de Bree, Remco
author_facet Mahieu, Rutger
den Toom, Inne J.
Boeve, Koos
Lobeek, Daphne
Bloemena, Elisabeth
Donswijk, Maarten L.
de Keizer, Bart
Klop, W. Martin C.
Leemans, C. René
Willems, Stefan M.
Takes, Robert P.
Witjes, Max J. H.
de Bree, Remco
author_sort Mahieu, Rutger
collection PubMed
description Introduction: Nowadays, two strategies are available for the management of the clinically negative neck in early-stage (cT1-2N0) oral squamous cell carcinoma (OSCC): elective neck dissection (END) and sentinel lymph node biopsy (SLNB). SLNB stages both the ipsilateral and the contralateral neck in early-stage OSCC patients, whereas the contralateral neck is generally not addressed by END in early-stage OSCC not involving the midline. This study compares both incidence and hazard of contralateral regional recurrences (CRR) in those patients who underwent END or SLNB. Materials and Methods: A retrospective multicenter cohort study, including 816 lateralized or paramedian early-stage OSCC patients, staged by either unilateral or bilateral END (n = 365) or SLNB (n = 451). Results: The overall rate of occult contralateral nodal metastasis was 3.7% (30/816); the incidence of CRR was 2.5% (20/816). Patients who underwent END developed CRR during follow-up more often than those who underwent SLNB (3.8 vs. 1.3%; p = 0.018). Moreover, END patients had a higher hazard for developing CRR than SLNB patients (HR = 2.585; p = 0.030). In addition, tumor depth of invasion was predictive for developing CRR (HR = 1.922; p = 0.009). Five-year disease-specific survival in patients with CRR was poor (42%) compared to patients in whom occult contralateral nodal metastases were detected by SLNB or bilateral END (88%), although not statistically different (p = 0.066). Conclusion: Our data suggest that SLNB allows for better control of the contralateral clinically negative neck in patients with lateralized or paramedian early-stage OSCC, compared to END as performed in a clinical setting. The prognosis of those in whom occult contralateral nodal metastases are detected at an earlier stage may be favorable compared to those who eventually develop CRR, which highlights the importance of adequate staging of the contralateral clinically negative neck.
format Online
Article
Text
id pubmed-8103896
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81038962021-05-08 Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort Mahieu, Rutger den Toom, Inne J. Boeve, Koos Lobeek, Daphne Bloemena, Elisabeth Donswijk, Maarten L. de Keizer, Bart Klop, W. Martin C. Leemans, C. René Willems, Stefan M. Takes, Robert P. Witjes, Max J. H. de Bree, Remco Front Oncol Oncology Introduction: Nowadays, two strategies are available for the management of the clinically negative neck in early-stage (cT1-2N0) oral squamous cell carcinoma (OSCC): elective neck dissection (END) and sentinel lymph node biopsy (SLNB). SLNB stages both the ipsilateral and the contralateral neck in early-stage OSCC patients, whereas the contralateral neck is generally not addressed by END in early-stage OSCC not involving the midline. This study compares both incidence and hazard of contralateral regional recurrences (CRR) in those patients who underwent END or SLNB. Materials and Methods: A retrospective multicenter cohort study, including 816 lateralized or paramedian early-stage OSCC patients, staged by either unilateral or bilateral END (n = 365) or SLNB (n = 451). Results: The overall rate of occult contralateral nodal metastasis was 3.7% (30/816); the incidence of CRR was 2.5% (20/816). Patients who underwent END developed CRR during follow-up more often than those who underwent SLNB (3.8 vs. 1.3%; p = 0.018). Moreover, END patients had a higher hazard for developing CRR than SLNB patients (HR = 2.585; p = 0.030). In addition, tumor depth of invasion was predictive for developing CRR (HR = 1.922; p = 0.009). Five-year disease-specific survival in patients with CRR was poor (42%) compared to patients in whom occult contralateral nodal metastases were detected by SLNB or bilateral END (88%), although not statistically different (p = 0.066). Conclusion: Our data suggest that SLNB allows for better control of the contralateral clinically negative neck in patients with lateralized or paramedian early-stage OSCC, compared to END as performed in a clinical setting. The prognosis of those in whom occult contralateral nodal metastases are detected at an earlier stage may be favorable compared to those who eventually develop CRR, which highlights the importance of adequate staging of the contralateral clinically negative neck. Frontiers Media S.A. 2021-04-23 /pmc/articles/PMC8103896/ /pubmed/33968742 http://dx.doi.org/10.3389/fonc.2021.644306 Text en Copyright © 2021 Mahieu, den Toom, Boeve, Lobeek, Bloemena, Donswijk, de Keizer, Klop, Leemans, Willems, Takes, Witjes and de Bree. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Mahieu, Rutger
den Toom, Inne J.
Boeve, Koos
Lobeek, Daphne
Bloemena, Elisabeth
Donswijk, Maarten L.
de Keizer, Bart
Klop, W. Martin C.
Leemans, C. René
Willems, Stefan M.
Takes, Robert P.
Witjes, Max J. H.
de Bree, Remco
Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title_full Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title_fullStr Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title_full_unstemmed Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title_short Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
title_sort contralateral regional recurrence in lateralized or paramedian early-stage oral cancer undergoing sentinel lymph node biopsy—comparison to a historic elective neck dissection cohort
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103896/
https://www.ncbi.nlm.nih.gov/pubmed/33968742
http://dx.doi.org/10.3389/fonc.2021.644306
work_keys_str_mv AT mahieurutger contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT dentoominnej contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT boevekoos contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT lobeekdaphne contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT bloemenaelisabeth contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT donswijkmaartenl contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT dekeizerbart contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT klopwmartinc contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT leemanscrene contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT willemsstefanm contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT takesrobertp contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT witjesmaxjh contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort
AT debreeremco contralateralregionalrecurrenceinlateralizedorparamedianearlystageoralcancerundergoingsentinellymphnodebiopsycomparisontoahistoricelectiveneckdissectioncohort